Michael Chuong, Vice Chair and Medical Director of the Department of Radiation Oncology at Miami Cancer Institute, GI Section Editor at International Journal Radiation Oncology, Biology, Physics and Professor at FIU Herbert Wertheim College of Medicine, shared a post on LinkedIn:
“Glad to share our analysis published in IJROBP The Red Journal that included 161 patients and 175 lesions treated at Miami Cancer Institute, Florida International University – Herbert Wertheim College of Medicine and Ludwig – Maximilians – Universität München with ablative single – fraction SBRT
25 – 40 Gy x 1
Liver/lung targets most common
2 – yr LC 93.6%
Only 1 grade 3 AE
I’m excited that our multi – center randomized ph2 SCORCH trial of chemo +/- single – fraction SBRT (30 – 34 Gy x 1) for mCRC will open soon at several US centers! Stay tuned”
Title: Multi – Institutional Analysis of MR – Guided Single – Fraction Stereotactic Ablative Body Radiation Therapy: Feasibility, Safety, and Efficacy
Authors: Frederik Fuchs, Roberto Herrera, Rupesh Kotecha, Muni Rubens, Mukesh Roy, Kathryn E. Mittauer, Sina Mansoorian, Adeel Kaiser, Noah Kalman, Aurelie Gaasch, Sebastian N. Marschner, Nema Bassiri, Paul Rogowski, Chukwuka Eze, Claus Belka, Stefanie Corradini, Michael D. Chuong
Read the analysis
More posts featuring Michael Chuong